发明名称 |
NOVEL ANTI-IGF-IR ANTIBODIES AND USES THEREOF |
摘要 |
The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor (IGF-IR). The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR, stimulated either by IGF1 and/or IGF2, or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR and/or the IGF-I/Insulin hybrid receptor.
|
申请公布号 |
US2013125252(A1) |
申请公布日期 |
2013.05.16 |
申请号 |
US201313745142 |
申请日期 |
2013.01.18 |
申请人 |
PIERRE FABRE MEDICAMENT;PIERRE FABRE MEDICAMENT |
发明人 |
GOETSCH LILIANE;CORVAIA NATHALIE |
分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|